High-Dose Cholecalciferol Booster Therapy is Associated with a Reduced Risk of Mortality in Patients with COVID-19: A Cross-Sectional Multi-Centre Observational Study
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
High-Dose Cholecalciferol Booster Therapy is Associated with a Reduced Risk of Mortality in Patients with COVID-19: A Cross-Sectional Multi-Centre Observational Study
Authors
Keywords
-
Journal
Nutrients
Volume 12, Issue 12, Pages 3799
Publisher
MDPI AG
Online
2020-12-14
DOI
10.3390/nu12123799
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Editorial: low population mortality from COVID-19 in countries south of latitude 35 degrees North supports vitamin D as a factor determining severity
- (2020) Jonathan M. Rhodes et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- COVID-19 and vitamin D—Is there a link and an opportunity for intervention?
- (2020) Hrvoje Jakovac AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Considerations for Obesity, Vitamin D, and Physical Activity Amid the COVID‐19 Pandemic
- (2020) Stephen J. Carter et al. Obesity
- Optimal Nutritional Status for a Well-Functioning Immune System Is an Important Factor to Protect against Viral Infections
- (2020) Philip C. Calder et al. Nutrients
- Evidence that Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths
- (2020) William B. Grant et al. Nutrients
- Low serum 25‐hydroxyvitamin D (25[OH]D) levels in patients hospitalized with COVID‐19 are associated with greater disease severity
- (2020) Grigorios Panagiotou et al. CLINICAL ENDOCRINOLOGY
- Low plasma 25(OH) vitamin D level is associated with increased risk of COVID‐19 infection: an Israeli population‐based study
- (2020) Eugene Merzon et al. FEBS Journal
- Age and Multimorbidity Predict Death Among COVID-19 Patients
- (2020) Guido Iaccarino et al. HYPERTENSION
- Vitamin D insufficiency as a potential culprit in critical COVID‐19 patients
- (2020) Ruhul Munshi et al. JOURNAL OF MEDICAL VIROLOGY
- Vitamin D: A simpler alternative to tocilizumab for trial in COVID-19?
- (2020) Morry Silberstein MEDICAL HYPOTHESES
- Early nutritional supplementation in non-critically ill patients hospitalized for the 2019 novel coronavirus disease (COVID-19): Rationale and feasibility of a shared pragmatic protocol
- (2020) Riccardo Caccialanza et al. NUTRITION
- “Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: A pilot randomized clinical study”
- (2020) Marta Entrenas Castillo et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Association of Vitamin D Status and Other Clinical Characteristics With COVID-19 Test Results
- (2020) David O. Meltzer et al. JAMA Network Open
- The interplay between vitamin D and viral infections
- (2019) Majid Teymoori-Rad et al. REVIEWS IN MEDICAL VIROLOGY
- The concept of the personal vitamin D response index
- (2018) Carsten Carlberg et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Molecular evaluation of vitamin D responsiveness of healthy young adults
- (2017) Sabine Seuter et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Primary Vitamin D Target Genes Allow a Categorization of Possible Benefits of Vitamin D3 Supplementation
- (2013) Carsten Carlberg et al. PLoS One
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now